PODD
NasdaqINSULET CORP
Health Care, Health Care Equipment
$141.17
close 7 Aug 2026
-53.69%
52-week change
$9.79B
market cap
$126.40
$354.88
52-week range
Expected price
Expected price
$451.52 – $551.85
Current price
$141.17
Signal
Could be undervalued
A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.
Current multiples
P/E (TTM)26.49x
P/S (TTM)3.21x
P/B6.88x
EV/EBITDA (TTM)17.46x
FCF yield (TTM)3.00%
PEG (TTM, GAAP)0.10
Context
P/E, own 5-year average1,979.74x
P/E, sector median29.65x*
Price at 5-year median P/E$507.33*
Forward — analyst consensus
Forward P/E (FY2026)21.69x*
Forward P/E (FY2027)18.25x
Forward PEG1.15*
Consensus EPS FY2026 (23 analysts)$6.51
EPS growth (FY2026→FY2027)18.82%
Revenue growth (FY2026)21.54%
Street view
Price target (mean)$171.91*
Target upside21.77%
Ratings (buy / hold / sell)15 / 10 / 0
FY2026 EPS revisions, 30d (up / down)1 / 4
5-year history
Dashed line: average of month-end values
P/E (TTM)
P/S (TTM)
P/B
FCF yield (TTM)
period to 30 Jun 2026, filed 5 Aug 2026, close 7 Aug 2026
Discounted cash flow
Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.
Free cash flow, last ten years and TTM
Assumptions
As filed — not assumptions
Current price$141.17
Cash & equivalents—
Total debt$948.40M
Shares outstanding69.35M
Result
DCF price per share—
Current price$141.17
Margin of safety—
PV of years 1–10$2.52B
PV of terminal value$4.13B
Equity value—
Market-implied growth—
Projected FCF, years 1–10
Hover for PV and growth
Projection detail
Override growth for any year; blank years use the uniform rate
| Year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | Terminal |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth, % | 2.5 | ||||||||||
| FCF | $308.39M | $323.80M | $339.99M | $356.99M | $374.84M | $393.59M | $413.27M | $433.93M | $455.63M | $478.41M | $8.92B |
| PV | $285.54M | $277.61M | $269.90M | $262.40M | $255.11M | $248.03M | $241.14M | $234.44M | $227.93M | $221.59M | $4.13B |
period to 30 Jun 2026, filed 5 Aug 2026, close 7 Aug 2026